Medication-Assisted Treatment (MAT) in Florida: How Medical Stabilization and Therapy Work Together
You started Suboxone at an outpatient clinic three months ago, and the cravings quieted down, but you are still avoiding your family, still lying awake at night replaying the same shame loops, still struggling your way through triggers that therapy once a week cannot touch, and you are starting to wonder whether the medication is working as intended or whether something else needs attention.
Neither the medication nor you is broken. What you may be experiencing is the limitation of medication used alone. The Suboxone may be doing what it was designed to do, addressing physical cravings. But medication alone was never designed to address underlying trauma, shame, or co-occurring depression that may have been present long before substance use began. Those aspects of recovery often need additional support, and many people benefit from coordinated care where the person adjusting medication and the person providing therapy communicate regularly. That coordinated model is the foundation of the medication-assisted treatment Florida residents receive at Florida Oasis, a licensed provider in Lake Park, Florida.
Why “Just Take the Medication” Was Never the Whole Plan
Medication-assisted treatment is medical stabilization that may create space for therapeutic work. The Substance Abuse and Mental Health Services Administration, an agency within the U.S. Department of Health and Human Services, defines MAT as the use of FDA-approved medications combined with counseling and behavioral therapies, a whole-patient approach to the treatment of substance use disorders, because medication and therapy each address different aspects of recovery from addiction.
Here is the honest version. Buprenorphine, the active ingredient in Suboxone, and naltrexone, the active ingredient in Vivitrol, may help manage withdrawal symptoms and cravings. When your nervous system is less preoccupied with physical discomfort, you may find it easier to engage in therapy. But reducing physical symptoms is different from addressing underlying emotional wounds. Medication typically does not directly address childhood trauma, past assaults, or untreated depression that may have contributed to substance use. These underlying issues often require therapeutic attention, as unaddressed factors can complicate long-term recovery. Individual results vary.
At Florida Oasis in Lake Park, FL, MAT is offered using Suboxone (buprenorphine), Vivitrol (naltrexone), and psychiatric medications when clinically appropriate, for individuals seeking support for opioid and alcohol use concerns alongside mental health conditions. Medication is viewed as one component of a broader treatment approach that includes therapy and other supports.
How Stabilizing Your Brain May Open a Door Therapy Can Walk Through
When your brain is in survival mode, it can be difficult to engage in deeper therapeutic work. This is a neurobiological reality, not a character flaw. A brain managing cravings, withdrawal, and unmanaged panic may route most experiences through threat response pathways. This can leave limited capacity for reflection, grief processing, or memory reprocessing. MAT may help lower that threat signal, and for some people, this creates an opportunity for therapies like EMDR, DBT, and trauma work to become more accessible and potentially more effective.
Some people experience a plateau when using medication alone. At Florida Oasis, psychiatric conditions and substance use concerns are addressed concurrently from day one, rather than sequentially. MAT and psychiatric medication are managed on-site, with adjustments overseen by a board-certified psychiatrist who serves as medical director, supported by an ARNP, nursing staff who handle medication reconciliation and administration, and behavioral health technicians.
This is where the small program size may offer advantages. The house is capped at nine beds with a 1 to 1.5 daytime staff-to-client ratio, so the psychiatrist, clinicians, and technicians are in regular communication. The person monitoring your medication and the person guiding your therapy participate in the same daily clinical rounds about your care. In a house of nine, individualized attention is more feasible.
Outpatient Med Checks Versus Residential Medication-Assisted Treatment Florida: What May Change
The difference between outpatient MAT and residential dual-diagnosis MAT is the difference between periodic appointments and a clinical team that can adjust your care more frequently. In a standard outpatient model, you typically visit a prescriber’s office for a brief medication check, perhaps once a month, and fit therapy around other responsibilities. If a dose needs adjustment, because you feel foggy or cravings return, you may wait weeks for the next office appointment. There is no way to skip that gap, and during that waiting period, life continues, as do potential triggers.
Residential care may reduce that gap. Because prescribers are on-site and the house is small, medication can potentially be modified more promptly when needed. If you experience oversedation, anxiety, or side effects, this may be identified during daily rounds rather than weeks later. That responsiveness may offer support during early days when many people struggle.
And medication is only one component. At Florida Oasis, MAT is combined with individual therapy, group therapy, EMDR, DBT, CBT, interpersonal therapy, and somatic grounding, all delivered as coordinated treatment services in one location with the same clinical team. This matters for anyone searching for medication-assisted treatment Florida programs that extend beyond medication management alone. Many clinics provide medication and periodic appointments. When care is coordinated closely, the psychiatrist and primary clinician can align therapeutic interventions with your current medication status and needs, allowing therapy to be timed to your individual clinical picture.
When Standard Treatment Plateaus: Spravato, Ketamine, and TMS as Additional Options
For some people, co-occurring depression does not respond adequately to standard medication and therapy, regardless of coordination. This is where advanced interventions may be considered. Florida Oasis offers coordinated access to Spravato, ketamine, and TMS for clients whose co-occurring conditions have been treatment-resistant. Spravato (esketamine) is FDA-approved for treatment-resistant depression. These interventions are sometimes used because research suggests they may temporarily increase neuroplasticity, periods when the brain may be more receptive to forming new connections and modifying existing patterns. Individual responses vary.
These interventions may be more beneficial when coordinated with ongoing therapy. When a client receives Spravato or ketamine, the primary clinician may schedule EMDR or other therapies to align with periods when the brain may be more receptive to therapeutic work. When TMS is used, EMDR may be coordinated with the TMS schedule. This coordination happens during daily clinical rounds where the psychiatrist is also managing your medication-assisted treatment.
This integrated approach is what distinguishes coordinated care from simply having access to multiple treatment modalities. Coordinating neuroplasticity-related interventions with therapy requires close communication that may not occur when providers are at separate locations and communicate infrequently.
The Transition After Discharge, and How to Support Continuity
Many people do well in residential MAT but experience challenges in the weeks after discharge. This often occurs not because residential treatment was ineffective, but because continuity of care was disrupted. Transitioning to a new clinic, a new prescriber who doesn’t know your history, and a new therapist working from a discharge summary rather than direct knowledge of your story means that medication balance and therapeutic relationships often need to be rebuilt simultaneously. This transition challenge is recognized within the field.
One approach to supporting smoother transitions is maintaining connections to the same clinical team. Florida Oasis provides case management to map out next steps before discharge, and the program is actively building its own PHP (Partial Hospitalization Program) and IOP (Intensive Outpatient Program) so that clients can step down through lower levels of care while staying connected to the same psychiatrist and therapists. This continuity means medication doesn’t need to be restarted from scratch, and therapeutic work continues with familiar providers.
Consider the analogy of hospital discharge after major surgery. Responsible medical care includes a transition plan, follow-up, and continuity with providers who know what was done. Recovery from substance use and co-occurring conditions deserves similar continuity planning. Challenges that emerge in the months after residential care are often related to gaps in that transition planning.
Insurance, Access, and What the First 72 Hours Look Like
Residential MAT may be covered by commercial PPO plans when deemed medically necessary, pursuant to the terms of your plan, and coverage questions are often the first barrier families and clients encounter. Florida Oasis holds an active organizational contract with Cigna and Evernorth and is in-network with Aetna, Blue Cross Blue Shield, and Cigna, which may make residential MAT more accessible to clients with commercial PPO coverage and can reduce out-of-pocket costs.
The first 72 hours focus on initial stabilization and assessment. When medication-assisted treatment is initiated in residential care, the medical team focuses on managing withdrawal and cravings with Suboxone or Vivitrol as clinically appropriate, and adjusting doses as your body acclimates. The psychiatrist and ARNP review your progress in daily rounds, nursing staff handle medication administration and reconciliation following established procedures, and your primary clinician begins mapping the therapy plan around any mental health conditions. If you arrive while still using substances, that is anticipated and planned for. MAT can be initiated, and if you need medically supervised withdrawal first, that is coordinated with a medical detox partner. You do not need to be abstinent or fully stable to begin. You need to be willing to enter treatment.
Frequently Asked Questions
Can I start MAT if I am still using opioids or alcohol?
MAT induction can be initiated even if you are actively using when you arrive. The on-site psychiatrist and nursing team manage the process, and if you need medically supervised withdrawal first, that is coordinated with a medical detox partner before MAT continues in residential care.
How long does residential MAT treatment usually last?
Length depends on your clinical progress, any co-occurring conditions, and your insurance authorization. Most residential stays typically range between 30 and 90 days. Because Florida Oasis reviews care in daily clinical rounds, length of stay is based on your individual progress rather than a predetermined timeline.
Will I have to stop taking Suboxone or Vivitrol to enter residential treatment?
No. Florida Oasis continues your current MAT regimen and adjusts it as needed in collaboration with the on-site psychiatrist. Entering residential care does not mean discontinuing your medication. It provides access to a team that can adjust it more frequently than monthly office appointments allow.
Does insurance cover residential MAT in Florida?
Many commercial PPO plans may cover residential medication-assisted treatment when deemed medically necessary. Florida Oasis is in-network with Cigna, Aetna, and Blue Cross Blue Shield and holds an active organizational contract with Cigna and Evernorth, which may lower out-of-pocket cost and streamline authorization for eligible plans.
What happens after I finish residential MAT treatment?
Florida Oasis provides case management to plan next steps and is building its own PHP and IOP so you can step down through lower levels of care while staying connected to the same psychiatrist and therapists, supporting continuity of care during the transition from residential treatment.
Can MAT help with alcohol use disorder, or is it only for opioids?
MAT is FDA-approved for both opioid and alcohol use disorders. At Florida Oasis, naltrexone (Vivitrol) is used for alcohol dependence, and both alcohol and opioid concerns are addressed concurrently with any co-occurring mental health conditions rather than sequentially.
Call Florida Oasis at the number on this page to verify your insurance benefits and coverage information and speak with an admissions specialist about how residential medication-assisted treatment and integrated therapy may support your recovery in Lake Park, FL. Medication may provide stabilization. The coordinated clinical team working with you daily in the same setting may support the therapeutic work that helps build sustainable recovery. Individual experiences and outcomes vary.
FDA Off-Label Use Disclosure: Spravato (esketamine) is FDA-approved for treatment-resistant depression. Ketamine for other uses is prescribed off-label (outside its original FDA approval) based on clinical judgment. Talk with your medical team to understand whether this treatment is right for you.
Take the First Step Toward Recovery That Lasts
If you’ve been wondering whether medication-assisted treatment could help you or someone you care about move beyond withdrawal and into real healing, the team at Florida Oasis in Lake Park is ready to answer your questions. Combining medical stabilization with ongoing support means you won’t face this alone, and you don’t have to have everything figured out before reaching out.
The post Medication-Assisted Treatment Florida: How Medical Stabilization and Therapy Work Together appeared first on Florida Oasis Mental Health Center.